Dr. med. Christina Bergmann

Department of Medicine 3 – Rheumatology and Immunology

Spatial multiomics decipher fibroblast–macrophage dynamics in systemic sclerosis (2025) Li Z, Rius Rigau AR, Xie W, Huang L, Ye W, Li YN, Matei AE, et al. Journal article Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study (2025) Hagen M, Müller F, Wirsching A, Kharboutli S, Spörl S, Düsing C, Krickau T, et al. Journal article Interstitial lung disease in anti-U1RNP systemic sclerosis patients: A European Scleroderma Trials and Research analysis (2025) Boleto G, Campochiaro C, Distler O, Balanescu A, Launay D, Bergmann C, Airò P, et al. Journal article Evaluation of Systemic Sclerosis Primary Heart Involvement and Chronic Heart Failure in the European Scleroderma Trials and Research Cohort. (2025) Györfi AH, Filla T, Polzin A, Tascilar K, Buch M, Tröbs M, Matei AE, et al. Journal article Exploring CAR T-Cell Dynamics: Balancing Potent Cytotoxicity and Controlled Inflammation in CAR T-Cells Derived from Systemic Sclerosis and Myositis Patients (2025) Dingfelder J, Taubmann J, von Heydebrand F, Aigner M, Bergmann C, Knitza J, Park S, et al. Journal article CD19-CAR T-cell therapy induces deep tissue depletion of B cells (2024) Tur C, Eckstein M, Velden J, Rauber S, Bergmann C, Auth J, Bucci L, et al. Journal article Imaging mass cytometry-based characterisation of fibroblast subsets and their cellular niches in systemic sclerosis (2024) Rigau AR, Liang M, Devakumar V, Neelagar R, Matei AE, Györfi AH, Bergmann C, et al. Journal article Noncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosis (2024) Trinh-Minh T, Chen CW, Tran-Manh C, Li YN, Zhu H, Zhou X, Chakraborty D, et al. Journal article CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series (2024) Auth J, Müller F, Völkl S, Bayerl N, Distler JH, Tur C, Raimondo MG, et al. Journal article Mutual Amplification of GLI2/Hedgehog and Transcription Factor JUN/AP-1 Signaling in Fibroblasts in Systemic Sclerosis: Potential Implications for Combined Therapies (2024) Bergmann C, Chenguiti Fakhouri S, Trinh-Minh T, Filla T, Rius Rigau AR, Ekici AB, Merlevede B, et al. Journal article